Ramalingam SS - Search Results

1

Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.

Owonikoko TK, Redman MW, Byers LA, Hirsch FR, Mack PC, Schwartz LH, Bradley JD, Stinchcombe TE, Leighl NB, Al Baghdadi T, Lara P Jr, Miao J, Kelly K, Ramalingam SS, Herbst RS, Papadimitrakopoulou V, Gandara DR. Owonikoko TK, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2021 May;22(3):187-194.e1. doi: 10.1016/j.cllc.2021.01.001. Epub 2021 Jan 10. Clin Lung Cancer. 2021. PMID: 33583720 Free PMC article. Clinical Trial.

2

Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.

Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. J Clin Oncol. 2007 Dec 10;25(35):5570-7. doi: 10.1200/JCO.2007.12.5435. J Clin Oncol. 2007. PMID: 18065729

3

Monoclonal antibodies versus tyrosine kinase inhibitors concurrent with chemotherapy in non-small-cell lung cancer: exploring divergent results.

Lara PN Jr, Ramalingam SS. Lara PN Jr, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2008 May;9(3):141-3. doi: 10.3816/CLC.2008.n.021. Clin Lung Cancer. 2008. PMID: 18621622 No abstract available.

4

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.

Belani CP, Schreeder MT, Steis RG, Guidice RA, Marsland TA, Butler EH, Ramalingam SS. Belani CP, et al. Among authors: ramalingam ss. Cancer. 2008 Nov 1;113(9):2512-7. doi: 10.1002/cncr.23902. Cancer. 2008. PMID: 18816622 Free article. Clinical Trial.

5

Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma.

Ramalingam SS, Belani CP, Ruel C, Frankel P, Gitlitz B, Koczywas M, Espinoza-Delgado I, Gandara D. Ramalingam SS, et al. J Thorac Oncol. 2009 Jan;4(1):97-101. doi: 10.1097/JTO.0b013e318191520c. J Thorac Oncol. 2009. PMID: 19096314 Free PMC article. Clinical Trial.

6

Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy.

Pakkala S, Ramalingam SS. Pakkala S, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Mar;10 Suppl 1:S17-23. doi: 10.3816/CLC.2009.s.003. Clin Lung Cancer. 2009. PMID: 19362942 Review.

7

Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.

Owonikoko TK, Ramalingam SS, Kanterewicz B, Balius TE, Belani CP, Hershberger PA. Owonikoko TK, et al. Among authors: ramalingam ss. Int J Cancer. 2010 Feb 1;126(3):743-55. doi: 10.1002/ijc.24759. Int J Cancer. 2010. PMID: 19621389 Free PMC article.

8

The role of cetuximab in the management of non-small-cell lung cancer.

Owonikoko TK, Sun SY, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Jul;10(4):230-8. doi: 10.3816/CLC.2009.n.031. Clin Lung Cancer. 2009. PMID: 19632939 Review.

9

Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigm.

Mok TS, Ramalingam SS. Mok TS, et al. Among authors: ramalingam ss. Cancer. 2009 Nov 15;115(22):5143-54. doi: 10.1002/cncr.24563. Cancer. 2009. PMID: 19658185 Free article. Review.

10

Preoperative therapy for early-stage NSCLC: opportunities and challenges.

Owonikoko TK, Khuri FR, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. Oncology (Williston Park). 2009 Sep;23(10):886, 889, 892. Oncology (Williston Park). 2009. PMID: 19839430 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

377 results

Search Page